Eli Lilly responded to its rivals accusations with a statement saying that the trial which underpins its advertising, known as Surmount-5, is the only direct, head-to-head randomised clinical trial comparing tirzepatide and semaglutide in the context of weight management
Because the study was retrospective in nature, it couldn't prove that GLP-1 discontinuation caused any excess in pregnancy risks, only find associations
Consult with healthcare providers about whether GLP-1 medications are appropriate for your individual health needs, particularly if you have thyroid conditions
PlexusDx recommends starting at the lowest therapeutic dose and titrating upward by no more than 0.25 mg per week to allow your body time to adapt
How many calories you need depends on your current weight, goal weight, and other factors, like any other health conditions you may have
En agosto de 2025, la FDA en Estados Unidos extendi la indicacin para semaglutida para ser incluida en el tratamiento de esteatohepatitis asociada al metabolismo (MASH) en adultos con moderado avance hacia la fibrosis (exceso de tejido de cicatrizacin en el hgado)